KF 18446 PET in the rat brain after quinolinic acid lesion : Comparison with the dopamine receptor imaging
暂无分享,去创建一个
M. Senda | K. Oda | H. Toyama | K. Ishiwata | T. Nagaoka | A. Tanaka | F. Suzuki | Kiichi ISHIWATA | Nobuo OGI | Nobutaka HAYAKAWA | Keiichi ODA | Tsukasa NAGAOKA | Hinako TOYAMA | Fumio SUZUKI | Kazutoyo ENDO | Akira TANAKA | Michio SENDA | N. Ogi | N. Hayakawa | K. Endo | Nobuo Ogi | Nobutaka Hayakawa
[1] S. Stone-Elander,et al. Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. , 1986, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.
[2] M. Senda,et al. Evaluation of carbon-11-labeled KF17837: a potential CNS adenosine A2a receptor ligand. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] J. Brotchi,et al. Quantitative assessment of quinolinic acid-induced striatal toxicity in rats using radioligand binding assays. , 1994, Neurological research.
[4] F. Tarazi,et al. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2- and D4-like receptors , 1998, Neuroscience.
[5] J. Noth,et al. Remote Microglial Activation in the Quinolinic Acid Model of Huntington's Disease , 1993, Experimental Neurology.
[6] J. Palacios,et al. Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease , 1991, Neuroscience.
[7] C. Gerfen,et al. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] J. van der Weide,et al. The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranes. , 1987, European journal of pharmacology.
[9] M. Levivier,et al. Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum , 1995, Neuroscience.
[10] E. Broussolle,et al. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson’s disease , 2001, Neurophysiologie Clinique/Clinical Neurophysiology.
[11] S. Synder,et al. Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[12] B. Fredholm,et al. Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography , 1995, Neuropharmacology.
[13] Adriaan A. Lammertsma,et al. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease , 1996, Journal of Neuroscience Methods.
[14] T. Dunwiddie,et al. The Role and Regulation of Adenosine in the Central Nervous System , 2022 .
[15] D. Mash,et al. Adenosine A2A receptor mRNA expression in Parkinson's disease , 2000, Neuroscience Letters.
[16] J. Fastbom,et al. The distribution of adenosine a1 receptors and 5'-nucleotidase in the brain of some commonly used experimental animals , 1987, Neuroscience.
[17] S. Augood,et al. Adenosine A2a receptor mRNA is expressed by enkephalin cells but not by somatostatin cells in rat striatum: a co-expression study. , 1994, Brain research. Molecular brain research.
[18] B B Fredholm,et al. Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic study , 1997, Synapse.
[19] Stoessl Aj,et al. NEURORECEPTOR IMAGING : NEW DEVELOPMENTS IN PET AND SPECT IMAGING OF NEURORECEPTOR BINDING (INCLUDING DOPAMINE TRANSPORTERS, VESICLE TRANSPORTERS AND POST SYNAPTIC RECEPTOR SITES) , 1998 .
[20] M. Senda,et al. Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone. , 2002, Nuclear medicine and biology.
[21] B. Ardekani,et al. A Fully Automatic Multimodality Image Registration Algorithm , 1995, Journal of computer assisted tomography.
[22] E. Grasbon-Frodl,et al. Antioxidant treatment protects striatal neurons against excitotoxic insults , 1996, Neuroscience.
[23] B. Fredholm,et al. Autoradiographic evidence for G-protein coupled A2-receptors in rat neostriatum using [3H]-CGS 21680 as a ligand , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.
[24] J. Fastbom,et al. Adenosine A1 receptors in the human brain: A quantitative autoradiographic study , 1987, Neuroscience.
[25] H. Kase. New Aspects of Physiological and Pathophysiological Functions of Adenosine A2A Receptor in Basal Ganglia , 2001, Bioscience, biotechnology, and biochemistry.
[26] Evaluation of iodinated and brominated [11C]styrylxanthine derivatives asin vivo radioligands mapping adenosine A2A receptor in the central nervous system , 2000, Annals of nuclear medicine.
[27] G. Fagg,et al. A comparative analysis of the neuroprotective properties of competitive and uncompetitive n-methyl-d-aspartate receptor antagonists in vivo: Implications for the process of excitotoxic degeneration and its therapy , 1993, Neuroscience.
[28] M. Dragunow,et al. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease , 2000, Neuroscience.
[29] M. Senda,et al. Comparison of three PET dopamine D2-like receptor ligands, [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone, in rats , 1999, Annals of nuclear medicine.
[30] D. Graham,et al. Specific alterations in local cerebral glucose utilization following striatal lesions , 1982, Brain Research.
[31] M. Toru,et al. An increase in [ 3 H ] CGS21680 binding in the striatum of postmortem brains of chronic schizophrenics , 1998, Brain Research.
[32] G Burnstock,et al. Nomenclature and Classification of Purinoceptors* , 2005 .
[33] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[34] D. Ingram,et al. In vivo assessment of adenoviral vector‐mediated gene expression of dopamine D2 receptors in the rat striatum by positron emission tomography , 2002, Synapse.
[35] B. Bloch,et al. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Senda,et al. An alternative synthesis of [11C]raclopride for routine use , 1999, Annals of nuclear medicine.
[37] C. Gerfen,et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.
[38] M. Senda,et al. Further characterization of a CNS adenosine A2a receptor ligand [11C]KF18446 within vitro autoradiography andin vivo tissue uptake , 2000, Annals of nuclear medicine.
[39] M. E. Lewis,et al. Autoradiographic visualization of rat brain adenosine receptors using N6-cyclohexyl [3H]adenosine. , 1981, European journal of pharmacology.
[40] M. Senda,et al. Quantitative ex vivo and in vitro receptor autoradiography using 11C-labeled ligands and an imaging plate: a study with a dopamine D2-like receptor ligand [11C]nemonapride. , 1999, Nuclear medicine and biology.
[41] J. Joseph,et al. Effect of aging on vulnerability of striatal D1 And D2 dopamine receptor-containing neurons to kainic acid , 1997, Brain Research.
[42] E. Wolters,et al. IBZM- and CIT-SPECT of the dopaminergic system in parkinsonism. , 1997, Journal of neural transmission. Supplementum.
[43] H Toyama,et al. A PET-MRI registration technique for PET studies of the rat brain. , 2000, Nuclear medicine and biology.
[44] T Ido,et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[45] H Toyama,et al. Synthesis and preliminary evaluation of [11C]KF17837, a selective adenosine A2A antagonist. , 1996, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[46] M. Senda,et al. 11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligand. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[47] M. Kiyosawa,et al. Carbon-11-labeled KF21213: a highly selective ligand for mapping CNS adenosine A(2A) receptors with positron emission tomography. , 2000, Nuclear medicine and biology.
[48] Helmut L. Haas,et al. Functions of neuronal adenosine receptors , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[49] S. Schiffmann,et al. Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study , 1991, Journal of neurochemistry.
[50] G. Wooten,et al. Differential localization of A2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons , 1993, Brain Research.